US Stock MarketDetailed Quotes
ENVB Enveric Biosciences
- 0.8400
- -0.0600-6.67%
Close May 17 16:00 ET
- 0.8123
- -0.0277-3.30%
Post 19:59 ET
6.51MMarket Cap-131P/E (TTM)
0.8850High0.8400Low210.20KVolume0.8700Open0.9000Pre Close181.15KTurnover2.74%Turnover RatioLossP/E (Static)7.75MShares6.980052wk High1.00P/B6.44MFloat Cap0.649052wk Low--Dividend TTM7.67MShs Float67500.0000Historical High--Div YieldTTM5.00%Amplitude0.6490Historical Low0.8610Avg Price1Lot Size
Enveric Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -8.34%18.3M | -11.86%4.23M | -39.04%3.45M | 22.27%5.76M | 1.35%4.86M | -26.26%19.96M | -63.42%4.8M | 60.85%5.66M | 39.96%4.71M | -32.11%4.8M |
| Selling and administrative expenses | -7.80%10.7M | -1.53%2.78M | -42.80%2.01M | 26.16%3.16M | 0.59%2.78M | -46.33%11.61M | -73.02%2.82M | 65.48%3.51M | 8.32%2.5M | -59.11%2.77M |
| -General and administrative expense | -7.80%10.7M | -1.53%2.78M | -42.80%2.01M | 26.16%3.16M | 0.59%2.78M | -46.33%11.61M | -73.02%2.82M | 65.48%3.51M | 8.32%2.5M | -59.11%2.77M |
| Research and development costs | -9.66%7.25M | -27.69%1.37M | -34.24%1.35M | 18.54%2.51M | 1.60%1.99M | 67.64%8.03M | -24.05%1.89M | 68.59%2.06M | 140.96%2.12M | 1,140.07%1.96M |
| Depreciation amortization depletion | 4.90%343.98K | -2.10%84.68K | -0.40%86.3K | 1.19%86.52K | 24.86%86.49K | -50.06%327.91K | -49.80%86.5K | -50.12%86.65K | -50.87%85.5K | -49.31%69.27K |
| -Depreciation and amortization | 4.90%343.98K | -2.10%84.68K | -0.40%86.3K | 1.19%86.52K | 24.86%86.49K | -50.06%327.91K | -49.80%86.5K | -50.12%86.65K | -50.87%85.5K | -49.31%69.27K |
| Operating profit | 8.34%-18.3M | 11.86%-4.23M | 39.04%-3.45M | -22.27%-5.76M | -1.35%-4.86M | 26.26%-19.96M | 63.42%-4.8M | -60.85%-5.66M | -39.96%-4.71M | 32.11%-4.8M |
| Net non-operating interest income expense | 170.64%3.71K | 519.26%566 | 826.30%2.24K | 237.13%916 | 99.73%-11 | 49.12%-5.25K | 97.37%-135 | 16.76%-308 | 86.14%-668 | -4.14K |
| Non-operating interest income | --3.71K | ---- | ---- | --916 | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | ---- | -99.73%11 | -49.12%5.25K | ---- | ---- | -86.14%668 | --4.14K |
| Total other finance cost | ---- | ---- | -826.30%-2.24K | ---- | ---- | ---- | ---- | --308 | ---- | ---- |
| Other net income (expense) | 10,976.86%1.03M | 115.26%818.41K | -80.16%630.54K | -131.40%-601.96K | -33.63%183.16K | 100.03%9.3K | 85.28%-5.36M | 294.89%3.18M | -22.06%1.92M | -92.76%275.97K |
| Gain on sale of security | -86.20%1.03M | -60.88%818.41K | -80.16%630.54K | -131.40%-601.96K | -33.63%183.16K | -19.99%7.46M | -7.03%2.09M | 294.89%3.18M | -22.06%1.92M | -92.76%275.97K |
| Special income (charges) | --0 | ---- | ---- | ---- | ---- | 80.73%-7.45M | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | -80.73%7.45M | ---- | ---- | ---- | ---- |
| Income before tax | 13.50%-17.26M | 66.41%-3.41M | -13.58%-2.82M | -127.77%-6.36M | -3.39%-4.68M | 64.63%-19.96M | 79.49%-10.16M | 8.61%-2.48M | -207.23%-2.79M | -39.17%-4.52M |
| Income tax | 101.95%28.91K | 101.50%22.32K | 6.6K | 80.07%-1.49M | -1.49M | 0 | ||||
| Net income | 6.39%-17.29M | 60.41%-3.44M | -13.85%-2.82M | -127.77%-6.36M | -3.39%-4.68M | 62.29%-18.47M | 79.39%-8.68M | 8.61%-2.48M | -207.23%-2.79M | -39.17%-4.52M |
| Net income continuous Operations | 6.39%-17.29M | 60.41%-3.44M | -13.85%-2.82M | -127.77%-6.36M | -3.39%-4.68M | 62.29%-18.47M | 79.39%-8.68M | 8.61%-2.48M | -207.23%-2.79M | -39.17%-4.52M |
| Minority interest income | -42.32%19.04K | 0 | 0 | -14.04%6.71K | 12.33K | 33.01K | 12.6K | 12.6K | 7.81K | 0 |
| Net income attributable to the parent company | 6.45%-17.31M | 60.46%-3.44M | -13.27%-2.82M | -127.38%-6.36M | -3.67%-4.69M | 62.22%-18.5M | 79.36%-8.69M | 8.14%-2.49M | -208.09%-2.8M | -39.17%-4.52M |
| Preferred stock dividends | -50.00%147.99K | 0 | -50.00%37K | 110.99K | 295.98K | 110.99K | 110.99K | 73.99K | ||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 7.14%-17.46M | 60.96%-3.44M | -8.44%-2.82M | -122.81%-6.4M | -6.12%-4.8M | 61.61%-18.8M | 79.10%-8.8M | 4.05%-2.6M | -216.23%-2.87M | -39.17%-4.52M |
| Basic earnings per share | 37.77%-8.09 | 69.94%-1.47 | 10.96%-1.3 | -11.36%-3.04 | 56.74%-2.31 | 87.46%-13 | 94.38%-4.89 | 75.30%-1.46 | -28.17%-2.73 | 46.60%-5.34 |
| Diluted earnings per share | 37.77%-8.09 | 69.94%-1.47 | 10.96%-1.3 | -11.36%-3.04 | 56.74%-2.31 | 87.46%-13 | 94.38%-4.89 | 75.30%-1.46 | -28.17%-2.73 | 46.60%-5.34 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
